With COVID-19, the world’s life science researchers and biopharma companies face an unprecedented challenge: They are mounting collaborative, industry-wide projects to discover and produce safe and effective therapies and vaccines as rapidly as possible.
In times like these, scientific researchers, drug developers and clinical study managers want experts who have the full breadth of knowledge and capabilities to support them so they can focus on their important work.
Avantor® is proud to collaborate with the companies on the forefront of COVID-19 research. They trust us to provide the solutions and services needed to fast-track virus detection, treatment development, clinical trials and production of existing and novel therapies to combat this pandemic.
From discovery to delivery, we provide mission-critical products and services to help scientists achieve research results faster and help manufacturers optimize their processes.
Our solutions are often specified in customers’ processes and products – and we are committed to delivering the resources and support needed to help drive breakthroughs across all viral detection and treatment development workflows.
Our mission of setting science in motion to create a better world is more important now than ever before.



